About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified OSAKA, Japan […]
Russias Ust-Luga Port Takes New Damage in Ukraine Drone Attack
...
Read moreDetails
